Literature DB >> 2725815

Urinary excretion of taurine in epilepsy.

S G Hartley1, H O Goodman, Z Shihabi.   

Abstract

Evidence that taurine (2-aminoethanesulfonic acid) is related to the epilepsies is supported by work with both experimental animals and humans. It may function as a neurotransmitter or modulator of neurotransmission. Investigators using an automated amino acid analyzer reported lower mean urinary taurine excretion among epileptics. However, Rao et al. reported higher taurine excretion among epileptics using an older method. Analyses of the same epileptic and control urines by both methods coupled with paper and molecular size chromatography indicate that substances in addition to taurine are co-eluted with taurine using the older method, yielding spuriously high values. The resolution of this disparity is important because the urinary excretion of taurine may reflect primarily the influence of taurine transport alleles which may be polygenic components in the idiopathic epilepsies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2725815     DOI: 10.1007/bf00969630

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  12 in total

1.  Electroencephalographic and biochemical study of the antiepileptic action of taurine administered by cortical superfusion.

Authors:  L Durelli; R Mutani; M M Delsedime; D G Quattrocolo; C Buffa; M Mazzarino; S Fumero
Journal:  Exp Neurol       Date:  1976-07       Impact factor: 5.330

2.  Antagonism by taurine of cobalt induced epilepsy in cat and mouse.

Authors:  N M Van Gelder
Journal:  Brain Res       Date:  1972-11-27       Impact factor: 3.252

3.  Ouabain-induced seizures in rats: suppressive effects of taurine and gamma-aminobutyric acid.

Authors:  K Izumi; J Donaldson; J L Minnich; A Barbeau
Journal:  Can J Physiol Pharmacol       Date:  1973-12       Impact factor: 2.273

4.  Automated analysis for taurine in biological fluids and tissues.

Authors:  H O Goodman; Z K Shihabi
Journal:  Clin Chem       Date:  1987-06       Impact factor: 8.327

5.  Urinary excretion of taurine in epilepsy.

Authors:  A Rao; L Baliga; A Raja; S N Rao
Journal:  Acta Neurol Scand       Date:  1983-12       Impact factor: 3.209

6.  Rapid liquid-chromatographic/fluorometric method for taurine in biological fluids, involving pre-derivatization with fluorescamine.

Authors:  T V Stabler; A L Siegel
Journal:  Clin Chem       Date:  1981-10       Impact factor: 8.327

7.  A rapid method for taurine quantitation using high performance liquid chromatography.

Authors:  B R Larsen; D S Grosso; S Y Chang
Journal:  J Chromatogr Sci       Date:  1980-05       Impact factor: 1.618

8.  Plasma and urinary taurine in epilepsy.

Authors:  B W Collins; H O Goodman; C H Swanton; C N Remy
Journal:  Clin Chem       Date:  1988-04       Impact factor: 8.327

9.  Reduced plasma haptoglobin and urinary taurine in familial seizures identified through the multisib strategy.

Authors:  J L Haines; S S Panter; S S Rich; J W Eaton; M Y Tsai; V E Anderson
Journal:  Am J Med Genet       Date:  1986-08

10.  Antiepileptic drugs and plasma and platelet taurine in epilepsy.

Authors:  H O Goodman; Z Shihabi; K S Oles
Journal:  Epilepsia       Date:  1989 Mar-Apr       Impact factor: 5.864

View more
  1 in total

1.  Anticonvulsant activity, teratogenicity and pharmacokinetics of novel valproyltaurinamide derivatives in mice.

Authors:  Nina Isoherranen; Boris Yagen; Ofer Spiegelstein; Richard H Finnell; Michelle Merriweather; Jose H Woodhead; Bogdan Wlodarczyk; H Steve White; Meir Bialer
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.